Quantcast

Dr. Jerry Shay Joins Life Length as Scientific Advisor

March 31, 2011

MADRID, March 31, 2011 /PRNewswire/ — Life Length the new biotechnology
company that measures the length of telomeres, announced that Dr. Jerry W.
Shay
has been appointed as a Scientific Advisor.

Stephen J. Matlin, CEO, Life Length said, “We are delighted to welcome
Dr. Shay, one of the foremost world experts on aging and cancer to Life
Length.” Jerry W. Shay is Vice Chairman of the Department of Cell Biology at
The University of Texas Southwestern Medical Center in Dallas, Associate
Director of the Harold Simmon’s Comprehensive Cancer Center, and holds the
Southland Corporation Distinguished Chair in Aging and Cancer Research. He is
Director of the Cancer Biology Graduate Program. His seminal work on the
relationships of telomerase to aging and cancer has received much
international recognition. He received the AlliedSignal Award, the American
Association of Aging Hayflick Award, and the Ted Nash Foundation Award. Dr.
Shay was named an Ellison Medical Foundation Senior Scholar.

Dr. Shay said, “Life Length uses the technique developed by Dr. Blasco
which measures each individual telomere cell-by-cell with enormous precision.
Currently all other approaches only provide average telomere length which has
limited usefulness. Whereas, Life Length’s approach has the critical
advantage of learning about the shortest telomeres at the individual cell
level, which have the greatest impact on cell senescence and aging. This
technology provides information at the cell and tissue level about
heterogeneity that is important and clearly exists between cells in a mixed
population enabling identification, for example, of a rare stem cell that may
have longer telomeres. Thus, Life Length’s technology is far superior.”

About Life Length

Life Length, S.L. is the new biotechnology company established in
September 2010 to commercially exploit the telomere length measuring
technique known as TAT (Telomere Analysis Technology), developed by Dr. Maria
Blasco
, Chief Scientific Advisor, Life Length, at the Spanish National Cancer
Research Centre (CNIO), providing them to the pharmaceutical industry,
hospitals and clinics, as well as research laboratories interested in
measuring telomeres as indicators of biological age and the overall health of
an organism. Life Length has an exclusive arrangement with CNIO to exploit
TAT measurement technology and it is the first company in the world to offer
these services. The founding partners of Life Length are the Botin
Foundation, Dr. Maria Blasco and Matlin Associates. http://www.lifelength.com

    Media Contact:

    Jaime de Pinies, Pinies & Aguilar
    +34-91-183-2101, jdepinies@pinies-aguilar.com

SOURCE Life Length


Source: newswire



comments powered by Disqus